Bluefin Capital Management, LLC Moderna, Inc. Call Options Transaction History

Bluefin Capital Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 16, 2024	SELL	$69.51 - $104.43 $437,913 - $657,909	-6,300 Reduced 17.26%	30,200 $3 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $1.07 Million - $1.41 Million	-11,100 Reduced 23.32%	36,500 $3.77 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $5.64 Million - $7.64 Million	47,600 New	47,600 $5.78 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $4.66 Million - $8.28 Million	39,400 New	39,400 $7.08 Million

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bluefin Capital Management, LLC with notifications on news.